Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.637, 2011-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Somatropin provides long-term QOL improvement in GHD
Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. :
Access to resources
Recommend
Long-term androgen suppression impact on QOL "acceptable"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. :
Neoadjuvant chemotherapy: long-term benefit in osteosarcoma
Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. :
Enfuvirtide-based treatment provides long-term benefit
Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. :
Interferons in MS: long-term clinical benefit uncertain
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :